Maximize scientific insight. Minimize animal use.

MAAP turns every preclinical animal into a rich, reusable research asset—linking FAIR metadata, 3Rs, and AI so teams run fewer repeats and make earlier go/no-go decisions.

What is MAAP?

Vision: Extract maximum scientific value from every animal used.
Problem: scattered spreadsheets and siloed systems force repeat studies and missed phenotypes.
Solution: a FAIR-by-design platform that structures metadata, monitors outcomes, and integrates with your lab stack—so studies are powered, traceable, and reusable.

MAAP is not a digital notebook or database plumbing. It turns animal experiments into structured, interoperable scientific assets that can be combined, compared, and reanalyzed without re-running cohorts.

Key pillars

Scientific rigor

Ontologies, standards, and interoperable metadata boost statistical power and translational probability.

Ethical responsibility (3Rs)

Reduction via reuse; refinement via better monitoring; replacement via better predictions.

Operational performance

Less reinventing data, accelerated timelines, and AI-ready assets for multi-site programs.

FAIR by design

MAAP isn't merely "compatible" with FAIR; it makes FAIR measurable:

  • Run multi-site studies without chaos.
  • Statistical power from better metadata, fewer repeats.
  • Traceable assets that feed AI/ML and regulatory packages.

See why MAAP is FAIR-by-design

Why Teams Choose MAAP

Accelerate and Simplify Research

Capture once, reuse everywhere—centralize and link data, metadata, and protocols to cut repeats.

Ensure Trust and Compliance

Ontology-driven, FAIR-by-design architecture with audit trails and SEND/ARRIVE-ready outputs.

Collaborate, Integrate, Innovate

Secure sharing across sites; LIMS/ELN/HCM integrations; assets ready for AI and regulators.

Workflows made visible

01

Capture

Investigations → Studies → Assays. Ingest from LIMS/ELN/AMS with lineage intact.

02

Standardize

JSON-LD + vocab validation so every subject and assay stays comparable. See <a href="/fair-by-design">FAIR</a>.

03

Reuse & Decide

Assets, not files: export, reanalyze, and compare across cohorts. Browse the <a href="/use-cases">use cases timeline</a>.

ROI and reduction

Fewer repeats

Better metadata → higher statistical power → fewer repeated experiments.

Earlier go/no-go

Better monitoring → fewer missed phenotypes → earlier decisions.

Less waste

Interoperability across sites → reduced duplication and cleaner transfers.

Quantify it

Ask: “How many mice could we reduce with 30% reuse of behavioral metadata?” Talk to us.

Q & A

Does MAAP replace my ELN or LIMS?

No. MAAP connects with your existing systems—ELNs, LIMS, HCM platforms—to avoid duplicate entry. It serves as a metadata hub that enriches, links, and harmonizes what you already capture.

What kind of data and standards does MAAP support?

MAAP manages preclinical metadata—subjects, protocols, devices, and outcomes—using ontology-based standards (JSON-LD, ARRIVE, FAIR, NWB soon) for full semantic consistency. Learn more in <a href="/fair-by-design">FAIR-by-Design</a>.

How does MAAP ensure FAIR, transparent, and ethical research?

MAAP records all subject and experiment life events, enabling traceability, reproducibility, and transparency aligned with ethical best practices.

What export and integration options are available?

Export to CSV, JSON, JSON-LD, and RO-CRATE (NWB coming soon), and integrate with analytics tools, publications, or repositories like OSF.

Who is MAAP for?

MAAP serves academic labs, CROs, and pharma teams. Its modular architecture scales from small studies to enterprise programs.

The Team

Damien Huzard

Damien Huzard

Founder, CEO & CSO

15 years in preclinical research and behavioral neuroscience; founded Ontaya, NeuroNautix, and built MAAP to improve metadata management.

Laurent Huzard

Laurent Huzard

Backend Backbone

API Platform specialist; reviews architecture, hardens code, and crafts reusable modules.

Frédéric Deverre

Frédéric Deverre

CCO

Business development leader with 20+ years in MedTech across hematology, cell therapy, and osteoarthritis. Shapes GTM, builds CRO/biopharma/academic partnerships, and drives commercialization that keeps preclinical metadata FAIR and usable. Native French; fluent in English and Spanish.

Have questions or want a demo?

Get in touch today.

Email us

Latest updates

View all